Marksans Pharma informs about press release

21 Aug 2024 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksans Pharma Limited’s wholly owned subsidiary Relonchem Limited receives Marketing Authorization for its products’.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

178.90 -3.15 (-1.73%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×